194 related articles for article (PubMed ID: 37705070)
1. Current and Future of "Turn-On" Based Small-Molecule Copper Probes for Cuproptosis.
Peng TE; Qiu F; Qu Y; Yu C; Cheng X; Li L
ChemistryOpen; 2023 Sep; 12(9):e202300078. PubMed ID: 37705070
[TBL] [Abstract][Full Text] [Related]
2. Copper homeostasis and cuproptosis in mitochondria.
Tian Z; Jiang S; Zhou J; Zhang W
Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
[TBL] [Abstract][Full Text] [Related]
3. Copper homeostasis and cuproptosis in health and disease.
Chen L; Min J; Wang F
Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis and its application in different cancers: an overview.
Xu L; Liu K; Wang F; Su Y
Mol Cell Biochem; 2023 Dec; 478(12):2683-2693. PubMed ID: 36914880
[TBL] [Abstract][Full Text] [Related]
5. Cuproptosis: mechanisms and links with cancers.
Xie J; Yang Y; Gao Y; He J
Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
[TBL] [Abstract][Full Text] [Related]
6. Contribution of cuproptosis and Cu metabolism-associated genes to chronic obstructive pulmonary disease.
Qi W; Liu L; Zeng Q; Zhou Z; Chen D; He B; Gong S; Gao L; Wang X; Xiong J; Cai D; Yu S; Zhao L
J Cell Mol Med; 2023 Dec; 27(24):4034-4044. PubMed ID: 37801050
[TBL] [Abstract][Full Text] [Related]
7. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
Han J; Luo J; Wang C; Kapilevich L; Zhang XA
Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
[TBL] [Abstract][Full Text] [Related]
8. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression.
Zhao Q; Qi T
Front Oncol; 2023; 13():1117164. PubMed ID: 36925927
[TBL] [Abstract][Full Text] [Related]
9. Polysiloxane-Based Molecular Logic Gate for Dual-Channel Visualizing Mitochondrial pH and Sulphite Changes during Cuproptosis.
Wang F; Lan Y; Zuo Y
Anal Chem; 2023 Sep; 95(38):14484-14493. PubMed ID: 37713336
[TBL] [Abstract][Full Text] [Related]
10. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
[TBL] [Abstract][Full Text] [Related]
11. Environmental copper exposure, placental cuproptosis, and miscarriage.
Zhao J; Xu Z; Wang X; Wan S; Chen W; Huang W; Wang M; Wang R; Zhang H
Environ Pollut; 2024 May; 348():123847. PubMed ID: 38552771
[TBL] [Abstract][Full Text] [Related]
12. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.
Yang L; Yang P; Lip GYH; Ren J
Trends Pharmacol Sci; 2023 Sep; 44(9):573-585. PubMed ID: 37500296
[TBL] [Abstract][Full Text] [Related]
13. Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy.
Chang J; Yin W; Zhi H; Chen S; Sun J; Zhao Y; Huang L; Xue L; Zhang X; Zhang T; Dong H; Li Y
Small; 2024 Feb; ():e2308565. PubMed ID: 38339770
[TBL] [Abstract][Full Text] [Related]
14. Stimulus-Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy.
Hu F; Huang J; Bing T; Mou W; Li D; Zhang H; Chen Y; Jin Q; Yu Y; Yang Z
Adv Sci (Weinh); 2024 Apr; 11(13):e2309388. PubMed ID: 38269649
[TBL] [Abstract][Full Text] [Related]
15. Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy.
Zhou J; Yu Q; Song J; Li S; Li XL; Kang BK; Chen HY; Xu JJ
Angew Chem Int Ed Engl; 2023 Mar; 62(12):e202213922. PubMed ID: 36585379
[TBL] [Abstract][Full Text] [Related]
16. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases.
Yang Y; Feng Q; Luan Y; Liu H; Jiao Y; Hao H; Yu B; Luan Y; Ren K
Front Pharmacol; 2023; 14():1229297. PubMed ID: 37637426
[TBL] [Abstract][Full Text] [Related]
17. Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy.
Guo B; Yang F; Zhang L; Zhao Q; Wang W; Yin L; Chen D; Wang M; Han S; Xiao H; Xing N
Adv Mater; 2023 Jun; 35(22):e2212267. PubMed ID: 36916030
[TBL] [Abstract][Full Text] [Related]
18. Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases.
Zou Y; Wu S; Xu X; Tan X; Yang S; Chen T; Zhang J; Li S; Li W; Wang F
Int Immunopharmacol; 2024 May; 133():112075. PubMed ID: 38663316
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of copper transporters in ovarian cancer cells and the prospect of cuproptosis.
Guo J; Sun Y; Liu G
J Inorg Biochem; 2023 Oct; 247():112324. PubMed ID: 37481825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]